Real World Treatment Patterns Among Patients with Psoriatic Arthritis Treated with Ixekizumab

被引:0
|
作者
Murage, Mwangi [1 ]
Princic, Nicole [2 ]
Park, Julie [2 ]
Malatestinic, William [1 ]
Zhu, Baojin [1 ]
Atiya, Bilal [1 ]
Kern, Scott [1 ]
Stenger, Keri [1 ]
Sprabery, Aubrey [1 ]
Ogdie, Alexis [3 ]
机构
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] IBM Watson Hlth, Cambridge, MA USA
[3] Univ Penn, Philadelphia, PA 19104 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1031
引用
收藏
页数:3
相关论文
共 50 条
  • [41] TREATMENT WITH IXEKIZUMAB FOLLOWING SECUKINUMAB FAILURE IN PATIENTS WITH PSORIATIC ARTHRITIS: REAL-LIFE EXPERIENCE FROM A RESISTANT POPULATION
    Berman, J.
    Furer, V.
    Berman, M.
    Isakov, O.
    Zisman, D.
    Haddad, A.
    Matz, H.
    Elkayam, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1309 - 1310
  • [42] USTEKINUMAB IS EFFECTIVE IN TREATING PSORIATIC SPONDYLITIS: REAL-WORLD DATA FROM PATIENTS TREATED FOR PERIPHERAL PSORIATIC ARTHRITIS
    Chan, Antoni
    Herdman, Linda
    Rigler, Kathryn
    Hicks, Susan
    RHEUMATOLOGY, 2017, 56 : 73 - 74
  • [43] Real-World Persistence and Treatment Patterns in Patients with Psoriatic Arthritis Treated with Anti-IL17 Therapy in Spain: The PerfIL-17 Study
    Beatriz Joven
    Concepción Fito Manteca
    Esteban Rubio
    Enrique Raya
    Alba Pérez
    Raquel Hernández
    Sara Manrique
    Mercedes Núñez
    Silvia Díaz-Cerezo
    Sebastián Moyano
    Alessandra Lacetera
    Rosario García-Vicuña
    Advances in Therapy, 2023, 40 : 5415 - 5431
  • [44] Real-World Persistence and Treatment Patterns in Patients with Psoriatic Arthritis Treated with Anti-IL17 Therapy in Spain: The PerfIL-17 Study
    Joven, Beatriz
    Fito Manteca, Concepcion
    Rubio, Esteban
    Raya, Enrique
    Perez, Alba
    Hernandez, Raquel
    Manrique, Sara
    Nunez, Mercedes
    Diaz-Cerezo, Silvia
    Moyano, Sebastian
    Lacetera, Alessandra
    Garcia-Vicuna, Rosario
    ADVANCES IN THERAPY, 2023, 40 (12) : 5415 - 5431
  • [45] COMPARISON OF SWITCHING PATTERNS AMONG PATIENTS WITH PSORIASIS USING IXEKIZUMAB OR SECUKINUMAB IN REAL-WORLD SETTINGS
    Blauvelt, A.
    Shi, N.
    Somani, N.
    Kern, S.
    Atiya, B.
    Burge, R.
    Ridenour, T.
    Zhu, B.
    Zimmerman, N.
    Murage, M.
    VALUE IN HEALTH, 2021, 24 : S17 - S18
  • [46] Secukinumab, ixekizumab, bimekizumab and brodalumab for the treatment of psoriasis and psoriatic arthritis
    Simopoulou, Theodora
    Tsiogkas, Sotirios G.
    Zafiriou, Efterpi
    Bogdanos, Dimitrios P.
    DRUGS OF TODAY, 2023, 59 (03) : 135 - 167
  • [47] REAL-WORLD TREATMENT PERSISTENCE WITH BIOLOGIC DISEASE MODIFYING ANTIRHEUMATIC DRUGS AMONG GERMAN PATIENTS WITH PSORIATIC ARTHRITIS
    Sewerin, P.
    Borchert, K.
    Meise, D.
    Mahlich, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1172 - 1172
  • [48] A Retrospective Study on the Effectiveness of Ixekizumab After Treatment With Secukinumab for Patients With Active Psoriatic Arthritis
    Darabian, Saman
    Badii, Maziar
    Dutz, Jan
    Chan, Jonathan
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1122 - 1123
  • [49] Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia
    Littlejohn, Geoffrey
    Leadbetter, Joanna
    Butcher, Belinda E.
    Feletar, Marie
    O'Sullivan, Catherine
    Smith, Tegan
    Witcombe, David
    Ng, Ho Yin
    Youssef, Peter
    CLINICAL RHEUMATOLOGY, 2024, 43 (05) : 1579 - 1589
  • [50] TREATMENT PATTERNS IN PSORIATIC ARTHRITIS IN US AND EUROPE: RESULTS FROM A REAL-WORLD INTERNATIONAL SURVEY
    Orbai, A. -M.
    Gossec, L.
    Lobosco, S.
    Moon, R.
    Massey, O.
    Piercy, J.
    Cappelleri, J. C.
    Fallon, L.
    Young, P.
    Romero, A. B.
    Hsu, M. -A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1578 - 1578